Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients
ConditionCervical Cancer
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexFemale
Age18-80
SponsorRuijin Hospital
About this trial
To evaluate if adjuvant concurrent chemoradiotherapy is associated with a recurrence-free survival benefit in comparison with radiotherapy alone in selected intermediate risk cervical cancer after radical surgery.
Eligibility criteria
Qualifiers
• 18 Years to 80 Years
Histologically proven cervical cancer, FIGO stage Ia2-IIb,and no previous chemotherapy and radiotherapy
Accepted radical hysterectomy 3-4 weeks before
Karnofsky score >70
Disqualifiers
• Postoperative residual
Postoperative recurrence or metastasis
Pelvic lymph node metastasis
parametrial invasion
Trial design
Treatments tested in this trial
- adjuvant concurrent chemoradiotherapy
- radiotherapy
Treatment groups
340 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov